Paul Edward Walker

Insider Reports History

Location
1954 Greenspring Drive, Suite 600, Timonium, MD
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Edward Walker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7.69M $146M $19.00 Jun 28, 2021 Indirect
Savara Inc 10%+ Owner Common Stock 24.5M $109M $4.45 Jul 17, 2023 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 1.09M $61.1M $56.00 Apr 22, 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Common Stock 3.61M $38.6M $10.69 Sep 16, 2024 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants 3M $5.7M $1.90 Apr 11, 2022 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 949K $1.92M $2.02 Apr 11, 2022 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2.56M $1.2M $0.47 Dec 22, 2021 Indirect
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 114 $3.2K $28.04 Jun 13, 2023 Indirect
Allakos Inc. Director Common Stock 0 $0 $0.32 May 15, 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 Oct 2, 2025 Indirect
Trevi Therapeutics, Inc. 10%+ Owner 3.5-Year Common Stock Warrant 1.85M Oct 18, 2021 Indirect
Trevi Therapeutics, Inc. 10%+ Owner 7-Year Common Stock Warrant 1.85M Oct 18, 2021 Indirect
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 Nov 30, 2022 Indirect
Allakos Inc. Director Stock Option (right to buy) 0 May 15, 2025 Direct
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 May 25, 2022 Indirect
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2.00 Jun 28, 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 $2.96 Jun 28, 2021 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series A Convertible Perpetual Preferred Stock 0 Oct 2, 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series B Convertible Perpetual Preferred Stock 0 Oct 2, 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 Oct 2, 2025 Indirect
Trillium Therapeutics Inc. Director Common Shares 0 Nov 17, 2021 Indirect
Trillium Therapeutics Inc. Director Series II Non-Voting Convertible First Preferred Shares 0 Nov 17, 2021 Indirect
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 Nov 17, 2021 Direct
Trillium Therapeutics Inc. Director Warrant to Purchase Common Shares 0 Nov 17, 2021 Indirect
Trillium Therapeutics Inc. Director Warrant to Purchase Series II Preferred Shares 0 Nov 17, 2021 Indirect

Insider Reports Filed by Paul Edward Walker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NEUE NeueHealth, Inc. Oct 2, 2025 31 $14.80 4 Oct 6, 2025 Director, 10%+ Owner
ALLK Allakos Inc. May 15, 2025 9 $0 4 May 15, 2025 Director
NEUE NeueHealth, Inc. Oct 1, 2024 3 $0 4 Oct 3, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 16, 2024 5 $8M 4 Sep 17, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 10%+ Owner
ALLK Allakos Inc. May 24, 2024 1 $0 4 May 29, 2024 Director
KRRO Korro Bio, Inc. Apr 22, 2024 1 $1M 4 Apr 24, 2024 10%+ Owner
NEUE NeueHealth, Inc. Apr 8, 2024 3 $0 4 Apr 10, 2024 10%+ Owner
BHG Bright Health Group Inc. Dec 19, 2023 1 $0 4 Dec 21, 2023 10%+ Owner
FREQ Korro Bio, Inc. Nov 3, 2023 0 $0 3 Nov 7, 2023 10%+ Owner
BHG Bright Health Group Inc. Oct 31, 2023 1 $0 4 Nov 2, 2023 10%+ Owner
BHG Bright Health Group Inc. Sep 15, 2023 1 $0 4 Sep 19, 2023 10%+ Owner
BHG Bright Health Group Inc. Aug 11, 2023 1 $0 4 Aug 16, 2023 10%+ Owner
SVRA Savara Inc Jul 17, 2023 1 $1M 4 Jul 19, 2023 10%+ Owner
MIRM Mirum Pharmaceuticals, Inc. Jun 13, 2023 4 $0 4 Jun 15, 2023 10%+ Owner
ALLK Allakos Inc. May 25, 2023 1 $0 4 May 30, 2023 Director
AKUS Akouos, Inc. Nov 30, 2022 1 $0 4 Dec 2, 2022 10%+ Owner
BHG Bright Health Group Inc. Oct 17, 2022 2 $138M 4 Oct 19, 2022 10%+ Owner
ALLK Allakos Inc. Sep 21, 2022 2 $20M 4 Sep 23, 2022 Director
ALLK Allakos Inc. May 25, 2022 1 $0 4 May 27, 2022 Director
GNCA GENOCEA BIOSCIENCES, INC. May 24, 2022 2 -$751K 4 May 26, 2022 10%+ Owner
TRVI Trevi Therapeutics, Inc. Apr 11, 2022 3 $12.5M 4 Apr 13, 2022 10%+ Owner
BHG Bright Health Group Inc. Jan 3, 2022 2 $200M 4 Jan 5, 2022 10%+ Owner
MTCR Metacrine, Inc. Dec 10, 2021 3 -$494K 4 Dec 27, 2021 10%+ Owner
TRIL Trillium Therapeutics Inc. Nov 17, 2021 5 $0 4 Nov 19, 2021 Director
TRVI Trevi Therapeutics, Inc. Oct 18, 2021 3 $0 4 Oct 19, 2021 10%+ Owner
BHG Bright Health Group Inc. Jun 28, 2021 12 $35M 4 Jun 30, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 7 $20M 4 Jun 30, 2021 10%+ Owner
BHG Bright Health Group Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 10%+ Owner
ALLK Allakos Inc. May 25, 2021 1 $0 4 Oct 14, 2021 Director